A study to investigate the absorption, metabolism, excretion and pharmacokinetics of [14C]-B9302-107 after oral and intravenous administration to six healthy male volunteers

*Please Note* The Study you are attempting to view was acquired from Takeda by AstraZeneca and was disclosed initially by Takeda per their Transparency Policies. More information regarding this study may be available by contacting [email protected].

An open-label, randomized, two-period crossover study in healthy male subjects.